Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.

Saved in:
Bibliographic Details
Title: Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.
Authors: Meijer J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Hermanns N; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Bijlsma R; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Blommestein HM; Erasmus School of Health Policy & Management, Rotterdam, the Netherlands., van den Bongard DHJG; Department of Radiation Oncology, Amsterdam UMC, Amsterdam, the Netherlands.; Cancer Center Amsterdam, Cancer Treatment and Quality of Life/Cancer Biology and Immunology, Amsterdam, the Netherlands., van Dalen T; Department of Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Drukker CA; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Paez CG; Dutch Breast Cancer Society (BVN), Utrecht, the Netherlands., Honkoop AH; Department of Medical Oncology, Isala Clinics, Zwolle, the Netherlands., Jager A; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands., Koppert LB; Department of Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Centre Utrecht, Utrecht, the Netherlands., van Maaren MC; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands., Siemerink EJ; Department of Medical Oncology, Ziekenhuisgroep Twente, Hengelo, the Netherlands., van 't LJ; University of California San Francisco, San Francisco, California, USA., Volders JH; Department of Surgery, Diakonessenhuis, Utrecht, the Netherlands., Vrancken Peeters MJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Surgery, Amsterdam University Medical Center, Amsterdam, the Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, the Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, the Netherlands.
Source: International journal of cancer [Int J Cancer] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1097-0215
DOI:10.1002/ijc.70571